Search Results - "Muntañola, Pedro"

Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model by Fernandez-Gomez, Jesus, Madero, Rosario, Solsona, Eduardo, Unda, Miguel, Martinez-Piñeiro, Luis, Gonzalez, Marcelino, Portillo, Jose, Ojea, Antonio, Pertusa, Carlos, Rodriguez-Molina, Jesus, Camacho, Jose Emilio, Rabadan, Mariano, Astobieta, Ander, Montesinos, Manuel, Isorna, Santiago, Muntañola, Pedro, Gimeno, Anabel, Blas, Miguel, Martinez-Piñeiro, Jose Antonio

“…Bacillus Calmette-Guerin is the most effective therapy for nonmuscle invasive bladder cancer. Recently to calculate the risks of recurrence and progression…”
Get more information

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables by Fernandez-Gomez, Jesus, Madero, Rosario, Solsona, Eduardo, Unda, Miguel, Martinez-Piñeiro, Luis, Ojea, Antonio, Portillo, Jose, Montesinos, Manuel, Gonzalez, Marcelino, Pertusa, Carlos, Rodriguez-Molina, Jesus, Camacho, Jose Emilio, Rabadan, Mariano, Astobieta, Ander, Isorna, Santiago, Muntañola, Pedro, Gimeno, Anabel, Blas, Miguel, Martinez-Piñeiro, Jose Antonio

“…Abstract Background European Organization for Research and Treatment of Cancer (EORTC) risk tables only included 171 patients treated with bacillus…”
Get full text

Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials by Fernandez-Gomez, Jesus, Solsona, Eduardo, Unda, Miguel, Martinez-Piñeiro, Luis, Gonzalez, Marcelino, Hernandez, Rafael, Madero, Rosario, Ojea, Antonio, Pertusa, Carlos, Rodriguez-Molina, Jesus, Camacho, Jose Emilio, Isorna, Santiago, Rabadan, Mariano, Astobieta, Ander, Montesinos, Manuel, Muntañola, Pedro, Gimeno, Anabel, Blas, Miguel, Martinez-Piñeiro, Jose Antonio

“…Abstract Objectives To evaluate the prognostic factors of recurrence and progression after intravesical adjuvant bacillus Calmette-Guérin (BCG) immunotherapy…”
Get full text

Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial by Solsona, Eduardo, Madero, Rosario, Chantada, Venancio, Fernandez, Jesus M, Zabala, Juan A, Portillo, José A, Alonso, Jose M, Astobieta, Ander, Unda, Miguel, Martinez-Piñeiro, Luis, Rabadan, Mariano, Ojea, Antonio, Rodriguez-Molina, Jesus, Beardo, Pastora, Muntañola, Pedro, Gomez, Matias, Montesinos, Manuel, Martinez Piñeiro, Jose A

“…Abstract Background Intravesical bacillus Calmette-Guérin (BCG) is an effective therapy in non–muscle-invasive bladder cancer (NMIBC), but it has limitations…”
Get full text

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013 by Martínez-Piñeiro, Luis, Portillo, José A, Fernández, Jesús M, Zabala, José A, Cadierno, Iker, Moyano, José L, Solsona, Eduardo, Unda, Miguel, Beardo, Pastora, Rodríguez-Molina, Jesús, Chantada, Venancio, Palou, Joan, Muntañola, Pedro, Alonso Dorrego, José M, Pérez-Garcia, Franciso J, Silva, Juan M, Chesa, Nicolás, Montesinos, Manuel, Ojea, Antonio, Madero, Rosario, Martínez-Piñeiro, José A

“…Abstract Background Bacillus Calmette-Guérin (BCG) maintenance therapy for 3 yr following BCG induction can reduce the progression of urothelial bladder…”
Get full text

Re: Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guerin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-Invasive Bladder Cancer in Intermediate-and High-Risk Patients: Final Outcome of CUETO 93009, A Randomized Prospective Trial by Eduardo Solsona, Rosario Madero, VenancioChantada

“…EAU Guideline recommendation in non-muscle invasive bladder cancer (NMIBC) is that patients who have intermediate or high risk for recurrence and intermediate…”
Get full text

Prognostic Factors in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin : Multivariate Analysis of Data from Four Randomized CUETO Trials. Commentary by FERNANDEZ-GOMEZ, Jesus, SOLSONA, Eduardo, EMILIO CAMACHO, Jose, ISORNA, Santiago, RABADAN, Mariano, ASTOBIETA, Ander, MONTESINOS, Manuel, MUNTANOLA, Pedro, GIMENO, Anabel, BIAS, Miguel, MARTINEZ-PINEIRO, Jose Antonio, SYLVESTER, Richard J, UNDA, Miguel, MARTINEZ-PINEIRO, Luis, GONZALEZ, Marcelino, HERNANDEZ, Rafael, MADERO, Rosario, OJEA, Antonio, PERTUSA, Carlos, RODRIGUEZ-MOLINA, Jesus

Get full text